Normalizing tumor blood vessels may improve immunotherapy against brain cancer

A type of immune therapy called chimeric antigen receptor (CAR)-T cell therapy has revolutionized the treatment of multiple types of blood cancers but has shown limited efficacy against glioblastoma—the deadliest type of primary brain cancer—and other solid tumors.

Leave A Comment

Your email address will not be published. Required fields are marked *